KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Short term Debt (2016 - 2025)

Elevance Health (ELV) has disclosed Short term Debt for 17 consecutive years, with $749.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Short term Debt rose 108.06% to $749.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $749.0 million, a 108.06% increase, with the full-year FY2024 number at $365.0 million, up 62.22% from a year prior.
  • Short term Debt was $749.0 million for Q3 2025 at Elevance Health, down from $1.6 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.9 billion in Q2 2024 to a low of $225.0 million in Q4 2023.
  • A 5-year average of $995.8 million and a median of $724.5 million in 2021 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: plummeted 83.43% in 2022, then surged 994.34% in 2024.
  • Elevance Health's Short term Debt stood at $1.6 billion in 2021, then plummeted by 83.43% to $265.0 million in 2022, then dropped by 15.09% to $225.0 million in 2023, then surged by 62.22% to $365.0 million in 2024, then skyrocketed by 105.21% to $749.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Short term Debt are $749.0 million (Q3 2025), $1.6 billion (Q2 2025), and $1.6 billion (Q1 2025).